Repare Therapeutics (RPTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist

1.290
+0.030+2.38%

Close Feb 25 16:00 ET

1.230
-0.060-4.65%

Post 20:01 ET

54.84MMarket Cap-0.65P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Repare Therapeutics Chief Medical Officer to Leave
MT Newswires13:09 ET
Repare Therapeutics Announces Major Reorganization in 2025
TipRanksFeb 25 06:37 ET
Express News | Repare Therapeutics Inc - Chief Medical Officer Maria Koehler to Leave Repare Therapeutics on March 31, 2025
ReutersFeb 25 06:15 ET
Express News | Repare Therapeutics Inc - Expects $7.3 Million in One-Time Cash Charges
ReutersFeb 25 06:15 ET
Express News | Repare Therapeutics Inc - to Reduce Workforce by Approximately 75%
ReutersFeb 25 06:15 ET
Repare Therapeutics (RPTX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks Jan 24 09:30 ET

Comments

Lnova

Feb 16 00:27

Ark Investment 1,999,996 shares
has options
$Repare Therapeutics (RPTX.US)$
nfa

Repare Therapeutics | SCHEDULE 13G/A: Others

Jaguar8

Jan 10 06:16

NEWS

$Repare Therapeutics (RPTX.US)$
Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
29 seconds ago, 4:15 AM PST
Via GlobeNewswire
RPRX
Share
• Royalty Pharma plc to become an integrated company by acquiring its external manager, RP Management, LLC
• Significant annual cash savings of greater than $100 million in 2026 growing to over $175 million in 2030, with cumulative savings of more than $1.6...

Jaguar8

Jan 9 15:25

NEWS

$Repare Therapeutics (RPTX.US)$
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
Realigning resources to extend runway to mid-2027
Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (Polθ ATPase inhibitor), with initial clinical readouts expected beginning in Q3 2025
Exploring partnerships for continued development of Lunre+Camo and other assets
January 09, 2025 04:05 PM Eastern Standard Time
CAMBRIDGE, Mass. & MONTREAL--...

WciStudios

Dec 13, 2024 13:26

$Repare Therapeutics (RPTX.US)$ lets crack 1.80 and at least hold

WciStudios

Dec 13, 2024 13:23

$Repare Therapeutics (RPTX.US)$

RPTX Repare Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks